Analyst picks & changes

Biogen Inc.

(BGEN)

Josephthal Lyon & Ross analyst Franklin Berger reiterated a "buy" on BGEN following the announcement that

Read the full 206 word article

How to gain access

Continue reading with a
two-week free trial.